Home › Breast Cancer › NCT06885203
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
Recruiting
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: Master Trainers: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Adult women aged 18 years and older 2. Histologically confirmed stage 0-III breast cancer 3. No evidence of metastatic disease 4. Self-identify as Black 5. Able to communicate in English Participants: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Adult women aged 18 years and older 2. Histologically confirmed stage 0-III breast cancer 3. No evidence of metastatic disease 4. Self-identify as Black 5. Able to communicate in English Community Interventionists: To be eligible to participate in this study, an individual must meet all the following criteria: 1. Adult women aged 18 years and older 2. Histologically confirmed stage 0-III breast cancer 3. No evidence of metastatic disease 4. Self-identify as Black 5. Former study participants that have completed the intervention 6. Able to communicate in English General Exclusion Criteria: 1. Men or woman below 18 years of age 2. Does not have a histologically confirmed breast cancer 3. There's evidence of metastatic disease 4. Does not self-identify as Black 5. Unable to communicate in English Additional Exclusion Criteria - Community Interventionists 1\. Has not previously participated in and completed the study intervention as a participant
About the study
The goal of this research study is to learn about the effects of the BBCSI course on the quality of life of Black breast cancer survivors.
A community-based and peer-led Black Breast Cancer Survivor's Intervention (BBCSI) course has been developed to help improve the quality of life of Black breast cancer survivors.
What is being tested
- Black Breast Cancer Survivor's Intervention (behavioral)
Sponsor: M.D. Anderson Cancer Center · Participants: 56 · Started: Aug 27, 2025
Contact the study team
- Dede Teteh-Brooks, DRPH · Phone: 713-563-3493
Official record on ClinicalTrials.gov — NCT06885203
Locations in the U.S.
| Texas | The University of Texas M. D. Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.